Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An encyclopedic regulatory and functional atlas of RNA interactomes.

Nature methods·2026
Same author

Author Correction: RIP-PEN-seq identifies a class of kink-turn RNAs as splicing regulators.

Nature biotechnology·2026
Same author

GlycoRNAdb: a database of glycoRNA sequences, structures, abundance, and glycan information across tissues and cell lines.

Nucleic acids research·2025
Same author

ENSURE: the encyclopedia of suppressor tRNA with an AI assistant.

Nucleic acids research·2025
Same author

Correction to "RNA-Guided RNA Modifications: Biogenesis, Functions, and Applications".

Accounts of chemical research·2024
Same author

NAP-seq reveals multiple classes of structured noncoding RNAs with regulatory functions.

Nature communications·2024

Related Experiment Video

Updated: May 30, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.8K

Targeting oncogene-induced cellular plasticity for tumor therapy.

Bin Li1, Lingling Zheng1, Jianhua Yang2,3

  • 1MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, Guangdong, China.

Advanced Biotechnology
|January 30, 2025
PubMed
Summary

Oncogenes drive cancer growth but can paradoxically promote metastasis when targeted. Understanding this cellular plasticity is key to developing effective cancer therapies that avoid increasing tumor spread.

Keywords:
Cellular plasticityEMTMetastasisOncogenePrecision medicine

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.4K
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.3K

Related Experiment Videos

Last Updated: May 30, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.8K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.4K
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

10.3K

Area of Science:

  • Oncology
  • Cancer Biology
  • Cellular Plasticity

Background:

  • Cellular plasticity enables cancer cells to adapt to stress, leading to treatment resistance, metastasis, and recurrence.
  • Oncogenes drive cell proliferation and tumorigenesis, but targeting them can paradoxically enhance cancer cell invasion.

Purpose of the Study:

  • To review current models of oncogene-driven cellular plasticity.
  • To explore how oncogenes can promote proliferation while simultaneously inhibiting metastasis.
  • To highlight the need for precision targeting strategies in cancer therapy.

Main Methods:

  • Literature review of oncogene function and cellular plasticity.
  • Analysis of signaling pathways involved in oncogene-induced epithelial-to-mesenchymal transition (EMT).
  • Synthesis of models explaining the dual role of oncogenes in proliferation and metastasis.

Main Results:

  • Oncogene targeting can induce epithelial-to-mesenchymal transition (EMT), enhancing metastatic potential.
  • Complex signaling networks mediate oncogene-induced cellular plasticity.
  • Some oncogenes concurrently promote proliferation and inhibit metastasis.

Conclusions:

  • Targeting oncogenes requires careful consideration of their impact on cellular plasticity and metastatic potential.
  • Multifaceted therapeutic approaches are needed to manage oncogene-driven cancers.
  • Precision targeting strategies should aim to inhibit oncogenes without promoting metastasis.